Spatial omics Market Report 2026

Spatial omics Market Overview

• Spatial omics market size has reached to $0.33 billion in 2025 • Expected to grow to $0.54 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Rising Prevalence Of Genetic Illnesses Drives Growth Of The Spatial Omics Market • Market Trend: Innovative Platforms Enable High-Resolution Mapping Of Gene Expression Across Tissues • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Spatial omics Market?

Spatial omics refers to an interdisciplinary field merging spatial analysis techniques with omics technologies to visualize and analyze biomolecules within their spatial context in tissues. It is a powerful tool that integrates spatial and molecular data to provide a comprehensive understanding of the organization and function of biological systems. The main products of the spatial omics market are instruments, consumables, and software. Spatial transcriptomics refers to a technology that allows scientists to study gene expression patterns within the context of tissue or cells, providing spatial information about where genes are active. The various sample types include formalin-fixed paraffin-embedded (FFPE), and fresh frozen the various workflows include sample preparation, instrumental analysis, and data analysis. The various technologies used are spatial transcriptomics, spatial genomics, and spatial proteomics used in various end-users such as academic and translational research institutes, and pharmaceutical and biotechnology companies.

What Is The Spatial omics Market Growth Forecast?

The spatial omics market size is expected to see rapid growth in the next few years. It will grow to $0.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing adoption in drug discovery workflows, rising investments in precision medicine research, expansion of AI-driven biological data analysis, growing demand for spatially resolved biomarkers, increasing pharmaceutical R&D spending. Major trends in the forecast period include increasing adoption of spatial transcriptomics platforms, rising integration of multi-omics data analysis, growing use of high-resolution imaging systems, expansion of advanced data visualization tools, enhanced focus on tissue-level molecular mapping.

Global Spatial omics Market Segmentation

1) By Product: Instruments, Consumables, Software 2) By Sample Type: Formalin-Fixed Paraffin-Embedded (FFPE), Fresh Frozen 3) By Workflow: Sample Preparation, Instrumental Analysis, Data Analysis 4) By Technology: Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics 5) By End-Use: Academic And Translational Research Institutes, Pharmaceutical And Biotechnology Companies Subsegments: 1) By Instruments: Spatial Transcriptomics Instruments, Imaging Systems, Mass Spectrometers 2) By Consumables: Reagents, Kits, Sample Preparation Materials 3) By Software: Data Analysis Software, Visualization Tools, Integration Platforms

What Is The Driver Of The Spatial omics Market?

The rising prevalence of genetic illnesses is expected to propel the growth of the spatial omics market. Genetic diseases refer to disorders caused by abnormalities in an individual's DNA inherited from one or both parents. Genetic diseases are rising due to increased awareness, improved diagnostic techniques, changes in lifestyle, and environmental factors contributing to mutations. Spatial omics technologies offer a powerful approach to studying genetic illnesses by providing detailed spatial maps of molecular and genetic features within tissues. For instance, in July 2025, according to the National Blood Authority, an Australia-based blood management agency, there were 2,788 patients living with hereditary haemophilia A (HMA) in 2023–2024, up from 2,681 patients in 2022–2023. Therefore, the rising prevalence of genetic illnesses is driving the growth of the spatial omics industry.

Key Players In The Global Spatial omics Market

Major companies operating in the spatial omics market are Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Luminex Corporation, Takara Bio Inc., Oxford Nanopore Technologies, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., CrestOptics, Indica Labs Inc., Resolve Biosciences GmbH, Pixelgen Technologies, Ionpath Inc., RareCyte Inc., S2 Genomics Inc., Vizgen Inc., BioSpyder Technologies, Ultivue Inc.

Global Spatial omics Market Trends and Insights

Major companies operating in the spatial omics market are focusing on developing innovative solutions, such as end-to-end spatial transcriptomics platforms, to enable comprehensive mapping of gene expression within tissue context for more precise biological insights. End-to-end spatial transcriptomics platforms are integrated systems that allow researchers to capture, visualize, and analyze gene expression across tissues in a single workflow, from sample preparation to data interpretation. For instance, in February 2025, Illumina Inc., a US-based biotechnology company, launched spatial transcriptomics technology designed to revolutionize tissue analysis and cellular mapping. Technology offers unbiased whole-transcriptome profiling at single-cell resolution with high sensitivity, enabling researchers to map complex tissues in unprecedented detail. It features a large capture area nine times bigger and four times greater in resolution than existing methods, allowing analysis of millions of cells per experiment and identification of rare cell types. The technology is integrated with Illumina's NextSeq and NovaSeq sequencers and paired with the Illumina Connected Multiomics (ICM) platform, which provides advanced multiomic visualization and analysis capabilities for comprehensive spatial data exploration.

What Are Latest Mergers And Acquisitions In The Spatial omics Market?

In May 2024, Bruker Corporation, a US-based manufacturer of scientific equipment for materials and molecular biology research, acquired the business of NanoString Technologies Inc. for approximately $392.6 million in cash. With this acquisition, Bruker aims to expand its spatial biology portfolio by adding gene expression profiling and spatial transcriptomics solutions and products. NanoString Technologies Inc. is a US-based company that provides molecular diagnostic products and life science tools for translational research.

Regional Outlook

North America was the largest region in the Spatial OMICS market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Spatial omics Market?

The spatial omics market includes revenues earned by entities by providing services such as spatial epigenomics, single-cell spatial analysis, spatial lipidomics and metabolomics, and multi-omics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial omics market consists of sales of spatial omics instrumentation, imaging systems, and imaging mass spectrometry. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.